ONLINE REGISTRATION IS NOW CLOSED.
WALK-INS ARE WELCOME!
Opioid addiction is a chronic, relapsing brain disease that affects millions of Americans and produces a tremendous burden on the healthcare system. In 2002, U.S. physicians gained the opportunity to treat opioid-addicted patients with buprenorphine in primary care settings, commonly referred to as office-based opioid treatment (OBOT). OBOT has been shown to be effective in primary care settings and impacts public health through the reduction of opioid use, opioid overdose mortality and transmission of infectious diseases. However, it remains underutilized.
One consistently cited barrier preventing OBOT expansion is lack of adequate clinical support given the additional needs for patient monitoring. Successful medication-assisted treatment (MAT) requires a team-based approach just like treatment for other chronic diseases. In addition, treatment is more effective when providers can use a trauma-informed and gender-responsive treatment plan.
The goal of this companion program to the AAAP Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders (The “Half and Half” Course) is to increase the comfort level and expertise of the healthcare team by outlining a team approach, trauma-informed interventions, gender-responsive care, and recommendations for implementation of buprenorphine OBOT.
MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.
Nurses, mental health professionals including substance abuse counselors, social workers, psychologists, marriage and family therapists, school counselors, practice managers, program administrators, medical assistants, care managers and coordinators and other professionals interested in this subject.
- Describe the presented framework of office-based opioid treatment (OBOT) including practice changes, medications used, psychosocial services and integration/coordination components
- Utilize evidence-based interventions that are trauma-informed and gender-responsive to treat persons with substance use disorders
- Define the roles of an effective practice team, including primary care and behavioral health clinicians, working together with patients and families, and using a systematic and cost-effective approach to provide patient-centered care for opioid and other substance use disorders
- Increase medical and behavioral health professionals’ receptivity and capability to work collaboratively as they evaluate and manage opioid and other substance use disorders using SBIRT (screening, brief intervention and referral to treatment)
- List key components of evidence-based and effective OBOT
- Marie N. Gannon, LPC, LCAS, CSI
- Melinda Ramage, MSN, FNP-BC, CARN-AP
- Zach T. White, LCSW, LCAS, CCS
- Courtenay Wilson, PharmD, BCACP, CPP